Pharma firm Almac announces pre-tax record profit of £48m

  • Craigavon-headquartered pharmaceutical firm Almac announced recently it made a a pre-tax profit of £48m on a record turnover of £634m in 2019.

    The Co Armagh firm said the results showed a "strong growth trajectory" and it now has more than 5,000 staff members as employment has also increased.

    The business also has major facilities in the Republic of Ireland, England, and the US.

    The results reflect a time before the Covid-19 pandemic, said the group’s chief executive, Alan Armstrong.

    He continued: "Since then, much has changed in our industry.

    "In response to the Covid-19 pandemic we continue to conduct our critical business operations across all our locations.

    "The health and safety of our employees and our ability to ensure the delivery of medicines to patients is, and always has been, our top priority and we are committed to ensure this continues."

    In May the company got a $288,000 (£230,000) grant to support a clinical study in sub-Saharan Africa in efforts to find a treatment for coronavirus, as reported by BBC News NI.

    It was awarded by the Covid-19 Therapeutics Accelerator, an initiative by the Bill & Melinda Gates Foundation, Wellcome and Mastercard.

    Almac's sciences division continues to conduct analytical and stability testing for the investigational drug and its clinical services division is providing clinical trial support such as packaging and distribution.

    About the author

    Niamh is a Sync NI writer with a previous background of working in FinTech and financial crime. She has a special interest in sports and emerging technologies. To connect with Niamh, feel free to send her an email or connect on Twitter.

    Got a news-related tip you’d like to see covered on Sync NI? Email the editorial team for our consideration.

Share this story